On both abstracts it is stated that the immune system has been activated and killed cancer cells. That's what we were told is the Holy Grail of oncology. The question is now to what extent that has happened. With some patients showing responses but then dying due to the organs already damaged beyond repair it is difficult to determine it exactly. Not sure if there a models out there to work out what could have been.
Anyway, Her-Vaxx and CF33 work and we now have to wait for BP to get hooked or not. The sp again reflects a total failure, but it is unlikely that IMU is fooling the world's scientists. At some stage someone will grab it, probably at cash value. Strange indeed, the medicos and patients want cancer to be cured and here comes IMU opening the door to cure it and nobody cares. Pfitzer paid 100m for a cough in the phone app, the same amount would now almost buy IMU, cash not considered.
Should have invested in weapon producers, their products are always in high demand. What a f..cked up world we're living in.
GLTA
- Forums
- ASX - By Stock
- Ann: Imugene HER-Vaxx and CHECKVacc to be Featured at ESMO
On both abstracts it is stated that the immune system has been...
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $364.4M |
Open | High | Low | Value | Volume |
4.8¢ | 5.0¢ | 4.8¢ | $219.7K | 4.505M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 54320 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 4763524 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 66118 | 0.049 |
53 | 5325664 | 0.048 |
44 | 4815772 | 0.047 |
44 | 2994131 | 0.046 |
59 | 6070008 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 4751822 | 25 |
0.051 | 6232776 | 15 |
0.052 | 2579418 | 10 |
0.053 | 1653210 | 10 |
0.054 | 1596999 | 6 |
Last trade - 11.09am 07/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
IMU (ASX) Chart |